We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Agilent Technologies | NYSE:A | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 140.61 | 13 | 12:00:00 |
By Patrick Thomas
Agilent Technologies Inc. (A) shares fell about 12% to $67.11 after the California manufacturer of laboratory equipment reported slower sales of its life-sciences instruments in China.
As a result, the firm lowered its revenue forecast for the current fiscal year to between $5.09 billion and $5.13 billion from between $5.15 billion and $5.19 billion.
In the latest period Agilent also posted lower-than-expected total revenue and said sales from its life sciences and applied markets business fell 1% from a year earlier.
Despite the weaker results, some analysts remain bullish on the company. SVB Leerink analysts said in a research note that Agilent is undervalued compared with its peers. The analysts maintained their "outperform" rating on the company's stock but lowered their price target to $80 from $86.
"We view Agilent positively and believe that the company holds the leading position in environmental, chemical, and food testing markets around the world while maintaining a well-diversified position across healthcare in biopharma, life science tools and diagnostics," the SVB analysts said in the note.
Write to Patrick Thomas at patrick.thomas@wsj.com
(END) Dow Jones Newswires
May 15, 2019 11:46 ET (15:46 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Agilent Technologies Chart |
1 Month Agilent Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions